Goldman Sachs upgrades Ibotta to Neutral from Sell, raises price target to $58 from $35

What happened

Goldman Sachs upgraded Ibotta from Sell to Neutral and raised its price target from $35 to $58. The new target was described as 65.7% higher than the previous target and implied 3.9% downside from Ibotta’s November 3 closing price of $60.35.

Confirmed

Global impact / market context

The higher target signals a less negative view from Goldman Sachs, but its Neutral rating is not a Buy recommendation. Because the $58 target was below the stated $60.35 closing price, it still indicated possible downside, which could shape investor expectations about Ibotta’s shares.

Analyst inference

Other recent analyst targets showed differing views: Wells Fargo maintained Equal-Weight at $49, Evercore ISI maintained In-Line at $58, and Needham maintained Buy at $65. The reported range of $49 to $65 indicates analysts did not share one view of Ibotta’s value.

Confirmed

What to watch

1. Check whether Goldman Sachs later changes its Neutral rating or $58 target; a revision would show whether its less negative assessment has strengthened or weakened. Analyst inference
2. Compare future Ibotta targets with the reported $49–$65 range and note whether new analyst views cluster more tightly or remain widely spread. Analyst inference
3. Watch for company results or guidance in any later coverage; this article provides no operating details to explain the rating change or establish its financial effects. Analyst inference

Evidence

• Original source link unavailable